In VitroCulture of Human Acute Myelogenous Leukemia (AML) Cells in Serum-Free Media: Studies of Native AML Blasts and AML Cell Lines
- 1 December 2000
- journal article
- research article
- Published by Mary Ann Liebert Inc in Journal of Hematotherapy & Stem Cell Research
- Vol. 9 (6) , 923-932
- https://doi.org/10.1089/152581600750062372
Abstract
The functional characteristics were compared for acute myelogenous leukemia (AML) cells (native blasts and AML cell lines) cultured in three serum-free media (X-vivo 10®, X-vivo 15®, [Bio-Whitacker, Walkersville, MD] and StemSpan™ [Stem Cell Technologies, Vancouver, BC, Canada]) and in medium containing 10% inactivated fetal calf serum (FCS). For native AML blasts the following functions were compared: (1) autonomous and cytokine-dependent proliferation; (2) frequency of clonogenic cell; and (3) constitutive cytokine secretion. AML blast proliferation differed between patients independent of the culture medium used, and clonogenic cells were maintained after in vitro culture in all media. In contrast, constitutive cytokine secretion was higher for cells cultured in StemSpan™ and FCS-containing medium than for cells cultured in the X-vivo® media. Native AML blasts incubated in StemSpan™ also showed a low frequency of apoptotic cells. The three serum-free media could also be used for long-term expansion of well-characterized AML cell lines, but the optimal medium for cell expansion and cytokine secretion differed between cell lines. We conclude that standardized serum-free culture conditions can be used for in vitro studies of native AML blasts and AML cell lines.Keywords
This publication has 12 references indexed in Scilit:
- Acute Myeloid LeukemiaNew England Journal of Medicine, 1999
- TrueLeukemia, 1999
- TrueLeukemia, 1999
- In Vitro Culture of Acute Myelogenous Leukemia Blasts: A Comparison of Four Different Culture MediaJournal of Hematotherapy, 1999
- Chemotherapy Compared with Autologous or Allogeneic Bone Marrow Transplantation in the Management of Acute Myeloid Leukemia in First RemissionNew England Journal of Medicine, 1998
- Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trialThe Lancet, 1998
- Autologous or Allogeneic Bone Marrow Transplantation Compared with Intensive Chemotherapy in Acute Myelogenous LeukemiaNew England Journal of Medicine, 1995
- Prognostic significance of the blast self-renewal capacity in patients with acute myeloid leukemiaCancer, 1994
- Autonomous growth of blast cells is associated with reduced survival in acute myeloblastic leukemiaBlood, 1993
- Human AML colony growth in serum-free cultureLeukemia Research, 1988